{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:05:12Z","timestamp":1794661512504,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.fertnstert.2021.07.1199","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:58:08Z","timestamp":1630025888000},"page":"611-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-7087","authenticated-orcid":false,"given":"Priyanka","family":"Bearelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella Juliet","family":"Avellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.07.1199_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib2","first-page":"255","article-title":"The use of alpha-adrenergic blockers in benign prostatic obstruction","volume":"48","author":"Caine","year":"1976","journal-title":"Br J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ucl.2016.04.009","article-title":"Alpha-blockers for the treatment of benign prostatic hyperplasia","volume":"43","author":"Lepor","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2490-12-29","article-title":"Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia","volume":"12","author":"Sakata","year":"2012","journal-title":"BMC Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0090-4295(99)80409-9","article-title":"The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia","volume":"47","author":"Roehrborn","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib6","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.juro.2013.12.014","article-title":"Change in sexual function in men with lower urinary tract symptoms\/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy","volume":"191","author":"Fwu","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-5347(01)67240-9","article-title":"Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study","volume":"154","author":"Fawzy","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(98)00126-5","article-title":"Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0022-5347(01)62386-3","article-title":"A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group","volume":"160","author":"Narayan","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-5347(05)00157-6","article-title":"Recovery of abnormal ejaculation by intermittent tamsulosin treatment","volume":"175","author":"Goktas","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib11","first-page":"148","article-title":"Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH\u2014a double-blind randomized trial","volume":"70","author":"Manohar","year":"2017","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.ijir.3901554","article-title":"Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia","volume":"19","author":"Rosen","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-410X.2006.06448.x","article-title":"Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men","volume":"98","author":"Kawabe","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib14","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.juro.2009.02.034","article-title":"Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies","volume":"181","author":"Marks","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2165\/00003088-199630010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of finasteride","volume":"30","author":"Steiner","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/andr.12353","article-title":"Sexual dysfunction in subjects treated with inhibitors of 5\u03b1-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis","volume":"5","author":"Corona","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0090-4295(94)90068-X","article-title":"Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia","volume":"43","author":"Stoner","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0090-4295(02)02401-9","article-title":"Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia","volume":"61","author":"Wessells","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jnci\/djm023","article-title":"Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial","volume":"99","author":"Moinpour","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib20","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/jsm.12525","article-title":"Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis","volume":"11","author":"Gacci","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group","volume":"39","author":"Kaufman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1464-410X.2009.08503.x","article-title":"Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia","volume":"104","author":"Rosen","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.juro.2018.05.048","article-title":"Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline","volume":"200","author":"Foster","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/iju.12866","article-title":"Systematic review of lower urinary tract symptoms\/benign prostatic hyperplasia surgical treatments on men\u2019s ejaculatory function: time for a bespoke approach?","volume":"23","author":"Marra","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/BF03346761","article-title":"Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up","volume":"36","author":"Favilla","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41443-019-0140-0","article-title":"The impact of surgery for lower urinary tract symptoms\/benign prostatic enlargement on both erectile and ejaculatory function: a systematic review","volume":"31","author":"Verze","year":"2019","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0022-5347(05)00983-3","article-title":"Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial","volume":"175","author":"Briganti","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/JU.0000000000000685","article-title":"Ejaculatory hood sparing versus standard laser photoselective vaporization of the prostate: sexual and urodynamic assessment through a double blinded, randomized trial","volume":"203","author":"Abolazm","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ijir.2014.22","article-title":"Pilot study of the clinical efficacy of ejaculatory hood sparing technique for ejaculation preservation in holmium laser enucleation of the prostate","volume":"27","author":"Kim","year":"2015","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0090-4295(99)80081-8","article-title":"Transurethral resection versus incision of the prostate: a randomized, prospective study","volume":"45","author":"Riehmann","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.afju.2012.04.007","article-title":"Transurethral incision versus transurethral resection of the prostate in small prostatic adenoma: long-term follow-up","volume":"18","author":"Abd-El Kader","year":"2012","journal-title":"African J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","article-title":"Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study","volume":"22","author":"Rukstalis","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bju.13714","article-title":"Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study","volume":"119","author":"Gratzke","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib34","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","article-title":"The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT study","volume":"190","author":"Roehrborn","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib35","first-page":"7772","article-title":"Three year results of the prostatic urethral LIFT study","volume":"22","author":"Roehrborn","year":"2015","journal-title":"Can J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","article-title":"WATER: a double-blind, randomized, controlled trial of aquablation \u00ae vs transurethral resection of the prostate in benign prostatic hyperplasia","volume":"199","author":"Gilling","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib38","article-title":"Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"2","author":"Hwang","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.eururo.2020.09.028","article-title":"Urethral-sparing robot-assisted simple prostatectomy: an innovative technique to preserve ejaculatory function overcoming the limitation of the standard Millin approach","volume":"80","author":"Porpiglia","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2018.06.005","article-title":"Robotic-assisted urethra-sparing simple prostatectomy via an extraperitoneal approach","volume":"119","author":"Wang","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/aja.2011.70","article-title":"Male sexual dysfunction and infertility associated with neurological disorders","volume":"14","author":"Fode","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.fertnstert.2021.07.1199_bib42","doi-asserted-by":"crossref","first-page":"212.e13","DOI":"10.1016\/j.fertnstert.2006.08.107","article-title":"Retrograde ejaculation: simpler treatment","volume":"88","author":"Leiva","year":"2007","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221017982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221017982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:32:57Z","timestamp":1758011577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221017982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0015028221017982"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1199","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}